Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 251–300 of 1,924 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05864105	PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma	completed	Phase 2	35	Biotheus Inc.INDUSTRY	1	Jul 9, 2026	clinicaltrials
NCT07689292	Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma(SKB264-Fru-GA)	not yet recruiting	Phase 2	45	Tianjin Medical University Cancer Institute and HospitalOTHER	0